Regulation of multidrug resistance through the cAMP and EGF signalling pathways
Open Access
- 1 July 1995
- journal article
- review article
- Published by Elsevier in Cellular Signalling
- Vol. 7 (5) , 431-443
- https://doi.org/10.1016/0898-6568(95)00018-k
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- P-glycoprotein, HER-2/neu, and Mutant p53 Expression in Human Gynecologic TumorsJNCI Journal of the National Cancer Institute, 1994
- Increased epidermal growth factor receptor in an estrogen‐responsive, adriamycin‐resistant MCF‐7 cell lineJournal of Cellular Physiology, 1993
- Role of site-selective cAMP analogs in the control and reversal of malignancyPharmacology & Therapeutics, 1991
- Expression of a P-glycoprotein gene is inducible in a multidrug resistant human leukemia cell lineBiochemical and Biophysical Research Communications, 1988
- Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREBNature, 1988
- A unique mRNA species for a regulatory subunit of cAMP‐dependent protein kinase is specifically induced in haploid germ cellsFEBS Letters, 1988
- cAMP mediated proteolysis of the catalytic subunit of cAMP‐dependent protein kinaseFEBS Letters, 1986
- Cyclic AMP-dependent protein kinase closes the serotonin-sensitive K+channels of Aplysia sensory neurones in cell-free membrane patchesNature, 1985
- A Model for the Chemical Interactions of Adenosine 3':5'-Monophosphate with the R Subunit of Protein Kinase Type I. Refinement of the Cyclic Phosphate Binding moiety of Protein Kinase Type IEuropean Journal of Biochemistry, 1979
- Evidence that rabbit muscle protein kinase has two kinetically distinct binding sites for adenosine 3′; 5′-cyclic monophosphateBiochemical and Biophysical Research Communications, 1978